Impact of Timing of Pharmacodynamic Assessment on Platelet Reactivity in Patients Treated With Cangrelor
Gespeichert in:
| Veröffentlicht in: | JACC. Cardiovascular interventions 2021-11, Vol.14 (21), p.2410-2412 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2412 |
|---|---|
| container_issue | 21 |
| container_start_page | 2410 |
| container_title | JACC. Cardiovascular interventions |
| container_volume | 14 |
| creator | Franchi, Francesco Rollini, Fabiana Galli, Mattia Been, Latonya Ghanem, Ghussan Shalhoub, Awss Rivas, Andrea Zhou, Xuan Pineda, Andres M Suryadevara, Siva Soffer, Daniel Zenni, Martin M Bass, Theodore A Angiolillo, Dominick J |
| description | |
| doi_str_mv | 10.1016/j.jcin.2021.07.051 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2594292818</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2594292818</sourcerecordid><originalsourceid>FETCH-LOGICAL-c347t-426360bbbfcaedb76e1b8fc577a29f3ab35b0d05a6268a5c421b66d03ab388263</originalsourceid><addsrcrecordid>eNo9kE1LAzEQhoMotlb_gAfJ0cuuSXY3yR5L8aNQsEjFY0iy2TbLftQkFfrvzdLqaYaZ5x2GB4B7jFKMMH1q0kbbPiWI4BSxFBX4AkwxZzRhFBWXsS8zmnBW8gm48b5BiKKSkWswyXKWUZbjKdgtu73UAQ413NjO9tuxW--k66QeqmMvO6vh3HvjfWf6yPVw3cpgWhPgh4lJ-2PDEdo4lsFGwsONMxGo4JcNO7iQ_daZdnC34KqWrTd35zoDny_Pm8Vbsnp_XS7mq0THp0KSE5pRpJSqtTSVYtRgxWtdMCZJWWdSZYVCFSokJZTLQucEK0orNG44j-EZeDzd3bvh-2B8EJ312rSt7M1w8IIUZU5KwjGPKDmh2g3eO1OLvbOddEeBkRgNi0aMhsVoWCAmouEYejjfP6jOVP-RP6XZLzKheX0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2594292818</pqid></control><display><type>article</type><title>Impact of Timing of Pharmacodynamic Assessment on Platelet Reactivity in Patients Treated With Cangrelor</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Franchi, Francesco ; Rollini, Fabiana ; Galli, Mattia ; Been, Latonya ; Ghanem, Ghussan ; Shalhoub, Awss ; Rivas, Andrea ; Zhou, Xuan ; Pineda, Andres M ; Suryadevara, Siva ; Soffer, Daniel ; Zenni, Martin M ; Bass, Theodore A ; Angiolillo, Dominick J</creator><creatorcontrib>Franchi, Francesco ; Rollini, Fabiana ; Galli, Mattia ; Been, Latonya ; Ghanem, Ghussan ; Shalhoub, Awss ; Rivas, Andrea ; Zhou, Xuan ; Pineda, Andres M ; Suryadevara, Siva ; Soffer, Daniel ; Zenni, Martin M ; Bass, Theodore A ; Angiolillo, Dominick J</creatorcontrib><identifier>ISSN: 1936-8798</identifier><identifier>EISSN: 1876-7605</identifier><identifier>DOI: 10.1016/j.jcin.2021.07.051</identifier><identifier>PMID: 34736741</identifier><language>eng</language><publisher>United States</publisher><subject>Adenosine Monophosphate - adverse effects ; Adenosine Monophosphate - analogs & derivatives ; Blood Platelets ; Humans ; Platelet Aggregation ; Platelet Aggregation Inhibitors - adverse effects ; Purinergic P2Y Receptor Antagonists - adverse effects ; Treatment Outcome</subject><ispartof>JACC. Cardiovascular interventions, 2021-11, Vol.14 (21), p.2410-2412</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c347t-426360bbbfcaedb76e1b8fc577a29f3ab35b0d05a6268a5c421b66d03ab388263</citedby><cites>FETCH-LOGICAL-c347t-426360bbbfcaedb76e1b8fc577a29f3ab35b0d05a6268a5c421b66d03ab388263</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27907,27908</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34736741$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Franchi, Francesco</creatorcontrib><creatorcontrib>Rollini, Fabiana</creatorcontrib><creatorcontrib>Galli, Mattia</creatorcontrib><creatorcontrib>Been, Latonya</creatorcontrib><creatorcontrib>Ghanem, Ghussan</creatorcontrib><creatorcontrib>Shalhoub, Awss</creatorcontrib><creatorcontrib>Rivas, Andrea</creatorcontrib><creatorcontrib>Zhou, Xuan</creatorcontrib><creatorcontrib>Pineda, Andres M</creatorcontrib><creatorcontrib>Suryadevara, Siva</creatorcontrib><creatorcontrib>Soffer, Daniel</creatorcontrib><creatorcontrib>Zenni, Martin M</creatorcontrib><creatorcontrib>Bass, Theodore A</creatorcontrib><creatorcontrib>Angiolillo, Dominick J</creatorcontrib><title>Impact of Timing of Pharmacodynamic Assessment on Platelet Reactivity in Patients Treated With Cangrelor</title><title>JACC. Cardiovascular interventions</title><addtitle>JACC Cardiovasc Interv</addtitle><subject>Adenosine Monophosphate - adverse effects</subject><subject>Adenosine Monophosphate - analogs & derivatives</subject><subject>Blood Platelets</subject><subject>Humans</subject><subject>Platelet Aggregation</subject><subject>Platelet Aggregation Inhibitors - adverse effects</subject><subject>Purinergic P2Y Receptor Antagonists - adverse effects</subject><subject>Treatment Outcome</subject><issn>1936-8798</issn><issn>1876-7605</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kE1LAzEQhoMotlb_gAfJ0cuuSXY3yR5L8aNQsEjFY0iy2TbLftQkFfrvzdLqaYaZ5x2GB4B7jFKMMH1q0kbbPiWI4BSxFBX4AkwxZzRhFBWXsS8zmnBW8gm48b5BiKKSkWswyXKWUZbjKdgtu73UAQ413NjO9tuxW--k66QeqmMvO6vh3HvjfWf6yPVw3cpgWhPgh4lJ-2PDEdo4lsFGwsONMxGo4JcNO7iQ_daZdnC34KqWrTd35zoDny_Pm8Vbsnp_XS7mq0THp0KSE5pRpJSqtTSVYtRgxWtdMCZJWWdSZYVCFSokJZTLQucEK0orNG44j-EZeDzd3bvh-2B8EJ312rSt7M1w8IIUZU5KwjGPKDmh2g3eO1OLvbOddEeBkRgNi0aMhsVoWCAmouEYejjfP6jOVP-RP6XZLzKheX0</recordid><startdate>20211108</startdate><enddate>20211108</enddate><creator>Franchi, Francesco</creator><creator>Rollini, Fabiana</creator><creator>Galli, Mattia</creator><creator>Been, Latonya</creator><creator>Ghanem, Ghussan</creator><creator>Shalhoub, Awss</creator><creator>Rivas, Andrea</creator><creator>Zhou, Xuan</creator><creator>Pineda, Andres M</creator><creator>Suryadevara, Siva</creator><creator>Soffer, Daniel</creator><creator>Zenni, Martin M</creator><creator>Bass, Theodore A</creator><creator>Angiolillo, Dominick J</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20211108</creationdate><title>Impact of Timing of Pharmacodynamic Assessment on Platelet Reactivity in Patients Treated With Cangrelor</title><author>Franchi, Francesco ; Rollini, Fabiana ; Galli, Mattia ; Been, Latonya ; Ghanem, Ghussan ; Shalhoub, Awss ; Rivas, Andrea ; Zhou, Xuan ; Pineda, Andres M ; Suryadevara, Siva ; Soffer, Daniel ; Zenni, Martin M ; Bass, Theodore A ; Angiolillo, Dominick J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c347t-426360bbbfcaedb76e1b8fc577a29f3ab35b0d05a6268a5c421b66d03ab388263</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adenosine Monophosphate - adverse effects</topic><topic>Adenosine Monophosphate - analogs & derivatives</topic><topic>Blood Platelets</topic><topic>Humans</topic><topic>Platelet Aggregation</topic><topic>Platelet Aggregation Inhibitors - adverse effects</topic><topic>Purinergic P2Y Receptor Antagonists - adverse effects</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Franchi, Francesco</creatorcontrib><creatorcontrib>Rollini, Fabiana</creatorcontrib><creatorcontrib>Galli, Mattia</creatorcontrib><creatorcontrib>Been, Latonya</creatorcontrib><creatorcontrib>Ghanem, Ghussan</creatorcontrib><creatorcontrib>Shalhoub, Awss</creatorcontrib><creatorcontrib>Rivas, Andrea</creatorcontrib><creatorcontrib>Zhou, Xuan</creatorcontrib><creatorcontrib>Pineda, Andres M</creatorcontrib><creatorcontrib>Suryadevara, Siva</creatorcontrib><creatorcontrib>Soffer, Daniel</creatorcontrib><creatorcontrib>Zenni, Martin M</creatorcontrib><creatorcontrib>Bass, Theodore A</creatorcontrib><creatorcontrib>Angiolillo, Dominick J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>JACC. Cardiovascular interventions</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Franchi, Francesco</au><au>Rollini, Fabiana</au><au>Galli, Mattia</au><au>Been, Latonya</au><au>Ghanem, Ghussan</au><au>Shalhoub, Awss</au><au>Rivas, Andrea</au><au>Zhou, Xuan</au><au>Pineda, Andres M</au><au>Suryadevara, Siva</au><au>Soffer, Daniel</au><au>Zenni, Martin M</au><au>Bass, Theodore A</au><au>Angiolillo, Dominick J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of Timing of Pharmacodynamic Assessment on Platelet Reactivity in Patients Treated With Cangrelor</atitle><jtitle>JACC. Cardiovascular interventions</jtitle><addtitle>JACC Cardiovasc Interv</addtitle><date>2021-11-08</date><risdate>2021</risdate><volume>14</volume><issue>21</issue><spage>2410</spage><epage>2412</epage><pages>2410-2412</pages><issn>1936-8798</issn><eissn>1876-7605</eissn><cop>United States</cop><pmid>34736741</pmid><doi>10.1016/j.jcin.2021.07.051</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1936-8798 |
| ispartof | JACC. Cardiovascular interventions, 2021-11, Vol.14 (21), p.2410-2412 |
| issn | 1936-8798 1876-7605 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2594292818 |
| source | MEDLINE; Elsevier ScienceDirect Journals; EZB-FREE-00999 freely available EZB journals |
| subjects | Adenosine Monophosphate - adverse effects Adenosine Monophosphate - analogs & derivatives Blood Platelets Humans Platelet Aggregation Platelet Aggregation Inhibitors - adverse effects Purinergic P2Y Receptor Antagonists - adverse effects Treatment Outcome |
| title | Impact of Timing of Pharmacodynamic Assessment on Platelet Reactivity in Patients Treated With Cangrelor |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T00%3A50%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20Timing%20of%20Pharmacodynamic%20Assessment%20on%20Platelet%20Reactivity%20in%20Patients%20Treated%20With%20Cangrelor&rft.jtitle=JACC.%20Cardiovascular%20interventions&rft.au=Franchi,%20Francesco&rft.date=2021-11-08&rft.volume=14&rft.issue=21&rft.spage=2410&rft.epage=2412&rft.pages=2410-2412&rft.issn=1936-8798&rft.eissn=1876-7605&rft_id=info:doi/10.1016/j.jcin.2021.07.051&rft_dat=%3Cproquest_cross%3E2594292818%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2594292818&rft_id=info:pmid/34736741&rfr_iscdi=true |